OpenVSafe by OpenVAERS
Search V-safe

FQJ-29943-08698

4 vaccinations 15 coded responses 51 check-ins 14 free-text entries 2 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
018 / MA
Registered
2021-04-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-11
    Registered in v-safe
  3. 2021-04-11
    Survey response — days 1–6 daily, dose 1
    MedDRA: Disturbance in attention — Feeling: Good · Site: Pain
    Free text: Harder to concentrate at times
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Disturbance in attention — Feeling: Fair · Site: Pain · Fatigue or tiredness
    Free text: Difficulty concentrating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-04-16
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  9. 2021-04-23
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-04-30
    Dose 2 — Pfizer-BioNTech
  11. 2021-04-30
    Survey response — day 0, dose 2
    MedDRA: Dizziness, Vision blurred — Feeling: Fair · Site: Pain · Fatigue or tiredness
    Free text: Dizziness, hard to focus
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-05-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  13. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  14. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  15. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  16. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-07
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-05-14
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-21
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-28
    Survey response — day 28, dose 2
    MedDRA: Menstruation delayed — Feeling: Good
    Free text: Late period
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-06-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-30
    Survey response — 3 months, dose 2
    MedDRA: Asthma, Chest discomfort, Cough, Pre-existing disease, Wheezing — Feeling: Good
    Free text: Asthma flare-ups (chest tightness, wheezing, coughing)
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  25. 2021-10-29
    Survey response — 6 months, dose 2
    MedDRA: Anxiety, Depression — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Anxiety and depression
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-10-29
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  27. 2021-11-02
  28. 2021-11-12
    Dose 3 — Pfizer-BioNTech
  29. 2021-11-12
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  30. 2021-11-13
    Survey response — days 1–6 daily, dose 3
    MedDRA: Asthma, Dyspnoea, Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities
    Free text: Shortness of breath (asthma exacerbations)
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-11-14
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness, Headache, Photophobia, Vision blurred — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: dizzyness and periods of blurred vision; light sensitivity with headache
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-11-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  33. 2021-11-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  34. 2021-11-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-11-18
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache
    Adult check-in
  36. 2021-11-19
    Health check-in — day 7, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  37. 2021-11-26
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-12-03
    Survey response — day 21, dose 3
    MedDRA: Headache — Feeling: Fair
    Free text: Headache
    MedDRA releases: 2024-11 · check-in free text available
  39. 2021-12-10
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-12-17
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-12-24
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  42. 2022-02-11
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  43. 2022-05-13
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  44. 2022-10-07
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  45. 2022-10-07
    Health check-in — day 0, dose 4
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  46. 2022-10-08
    Survey response — days 1–6 daily, dose 4
    MedDRA: Balance disorder, Dizziness — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Dizzy, wobbly
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-10-09
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  48. 2022-10-10
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Headache
    Adult check-in
  49. 2022-10-11
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  50. 2022-10-13
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Muscle or body aches
    Adult check-in
  51. 2022-10-14
    Health check-in — day 7, dose 4
    Feeling: Good · Headache
    Adult check-in
  52. 2022-10-21
    Survey response — day 14, dose 4
    MedDRA: Chest discomfort, Dyspnoea, Fatigue, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chest tightness, fatigue, shortness of breath (relapse of symptoms from health issues last few months)
    MedDRA releases: 2024-11 · check-in free text available
  53. 2022-10-28
    Survey response — day 21, dose 4
    MedDRA: Headache — Feeling: Fair
    Free text: Headache
    MedDRA releases: 2024-11 · check-in free text available
  54. 2022-11-04
    Survey response — day 28, dose 4
    MedDRA: Asthma, Cough, Respiratory tract congestion — Feeling: Good
    Free text: Coughing and chest congestion (likely asthma)
    MedDRA releases: 2024-11 · check-in free text available
  55. 2022-11-11
    Survey response — day 35, dose 4
    MedDRA: Cough, Respiratory tract congestion — Feeling: Good
    Free text: Cough, chest congestion
    MedDRA releases: 2024-11 · check-in free text available
  56. 2022-11-18
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  57. 2023-01-06
    Health check-in — 3 months, dose 4
    Feeling: Fair
    Adult check-in
  58. 2023-04-07
    Survey response — 6 months, dose 4
    MedDRA: Bronchitis, Candida infection, Medical counselling, Office visit — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  59. 2023-04-07
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  60. 2023-04-11
  61. 2023-04-11

Vaccinations

DoseDateManufacturerCo-administered
12021-04-09Pfizer-BioNTech
22021-04-30Pfizer-BioNTech
32021-11-12Pfizer-BioNTech No
42022-10-07Pfizer-BioNTech Flu

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-11

Systemic reaction (other): Harder to concentrate at times

2021-04-12

Systemic reaction (other): Difficulty concentrating

Release 8 — day 0, dose 2

2021-04-30

Systemic reaction (other): Dizziness, hard to focus

Release 8 — day 28, dose 2

2021-05-28

Symptoms: Late period

Release 9 — 3 months, dose 2

2021-07-30

Symptoms: Asthma flare-ups (chest tightness, wheezing, coughing)

Release 10 — 6 months, dose 2

2021-10-29

Symptoms: Anxiety and depression

Release 10 — days 1–6 daily, dose 3

2021-11-13

Systemic reaction (other): Shortness of breath (asthma exacerbations)

2021-11-14

Systemic reaction (other): dizzyness and periods of blurred vision; light sensitivity with headache

Release 10 — day 21, dose 3

2021-12-03

Symptoms: Headache

Release 12 — days 1–6 daily, dose 4

2022-10-08

Systemic reaction (other): Dizzy, wobbly

Release 12 — day 14, dose 4

2022-10-21

Symptoms: Chest tightness, fatigue, shortness of breath (relapse of symptoms from health issues last few months)

Release 12 — day 21, dose 4

2022-10-28

Symptoms: Headache

Release 12 — day 28, dose 4

2022-11-04

Symptoms: Coughing and chest congestion (likely asthma)

Release 12 — day 35, dose 4

2022-11-11

Symptoms: Cough, chest congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling · · ✓
HCVOOffice visit · · ✓
SDAnxiety · · ✓
SDAsthma ✓ · ✓
SDBronchitis · · ✓
SDCandida infection · · ✓
SDChest discomfort ✓ · ✓
SDCough ✓ · ✓
SDDepression · · ✓
SDDyspnoea · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDMenstruation delayed ✓ ✓ ✓
SDPre-existing disease ✓ · ✓
SDRespiratory tract congestion · · ✓
SDWheezing ✓ · ✓
SROAsthma · · ✓
SROBalance disorder · · ✓
SRODisturbance in attention ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SRODyspnoea · · ✓
SROHeadache · · ✓
SROPhotophobia · · ✓
SROPre-existing disease · · ✓
SROVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release